Cliniques universitaires Saint-Luc (CHU St-Luc)

Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis (2019) Starkel P, Schnabl B, Leclercq S, Komuta M, Bataller R, Argemi J, Palma E, et al. Journal article Regional Multi-View Learning for Cardiac Motion Analysis: Application to Identification of Dilated Cardiomyopathy Patients (2019) Puyol-Anton E, Ruijsink B, Gerber B, Amzulescu MS, Langet H, De Craene M, Schnabel JA, et al. Journal article A step towards international prospective trials in carbon ion radiotherapy: Investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma (2019) Vogin G, Wambersie A, Koto M, Ohno T, Uhl M, Fossati P, Balosso J Journal article PEDIA: prioritization of exome data by image analysis (2019) Hsieh TC, Mensah MA, Pantel JT, Aguilar D, Bar O, Bayat A, Becerra-Solano L, et al. Journal article Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms (2019) Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, Krejs GJ, et al. Journal article Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce Concepts et terminologie des paramètres de dose et volumes proposés en hadronthérapie par ions carbone (2018) Vogin G, Wambersie A, Poetter R, Beuve M, Combs SE, Magrin G, Mayer R, et al. Journal article MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies (2018) Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, et al. Conference contribution Immunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment (2018) Belaloui K, Malifarge E, Bohm J, Bossard C, Dienstmann R, Garcia S, Geppert CI, et al. Conference contribution Multiview machine learning using an atlas of cardiac cycle motion (2018) Puyol-Anton E, Sinclair M, Gerber B, Amzulescu MS, Langet H, De Craene M, Aljabar P, et al. Conference contribution Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article